Literature DB >> 19754752

Zygomycosis and diabetes mellitus.

F Lanternier1, O Lortholary.   

Abstract

Zygomycoses are severe angio-invasive fungal infections that develop in immunocompromised and diabetic patients. Any episode of sinusitis not responding to short-term antibacterial therapy should evoke the diagnosis of zygomycosis in the latter population, especially in cases of a surrounding necrotic area. Appropriate diagnosis is obtained after careful direct examination of the sample and culture. Current therapy underscores the need to control glycaemia and acidosis in addition to the need for urgent administration of high-dose liposomal amphotericin B in combination with extensive surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754752     DOI: 10.1111/j.1469-0691.2009.02975.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.

Authors:  Fabrice Compain; Nawel Aït-Ammar; Françoise Botterel; Laure Gibault; Francoise Le Pimpec Barthes; Eric Dannaoui
Journal:  Mycopathologia       Date:  2017-06-03       Impact factor: 2.574

Review 2.  Human Fungal Pathogens of Mucorales and Entomophthorales.

Authors:  Leonel Mendoza; Raquel Vilela; Kerstin Voelz; Ashraf S Ibrahim; Kerstin Voigt; Soo Chan Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

3.  Clinical course of rhinosinusitis and efficacy of sinonasal evaluation in kidney transplant recipients: review of 1589 patients.

Authors:  Gwanghui Ryu; Min Young Seo; Kyung Eun Lee; Hyo Yeol Kim; Hun-Jong Dhong; Seung-Kyu Chung; Sang Duk Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-20       Impact factor: 2.503

4.  Epidemiology of invasive fungal infections in kidney transplant patients.

Authors:  Behzad Einollahi
Journal:  Clin Epidemiol       Date:  2012-03-13       Impact factor: 4.790

5.  Mucormycosis in renal transplant recipients: review of 174 reported cases.

Authors:  Yan Song; Jianjun Qiao; Gaffi Giovanni; Guangjun Liu; Hao Yang; Jianyong Wu; Jianghua Chen
Journal:  BMC Infect Dis       Date:  2017-04-18       Impact factor: 3.090

6.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

Review 7.  Spectrum of Mucormycosis Before and During COVID-19: Epidemiology, Diagnosis, and Current Therapeutic Interventions.

Authors:  Sheikh Mansoor; Tousief Irshad Ahmed; Karan Happa; Mehnaz Sultan; Sweeta Manhas; Suhaib Shamas
Journal:  Curr Fungal Infect Rep       Date:  2022-08-10

Review 8.  Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.

Authors:  Bishan Radotra; Sundaram Challa
Journal:  Curr Fungal Infect Rep       Date:  2022-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.